JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB141245

Levofloxacin, Fluoroquinolone antibiotic

Be the first to review this product! Submit a review

|

(0 Publication)

MW 361.4 Da, Purity >98%. Fluoroquinolone antibiotic. Effective against Gram-positive and Gram-negative bacteria. Pharmacologically active following oral administration. Crosses the blood-brain barrier.
1 Images
Chemical Structure - Levofloxacin, Fluoroquinolone antibiotic (AB141245)
  • Chemical Structure

Lab

Chemical Structure - Levofloxacin, Fluoroquinolone antibiotic (AB141245)

2D chemical structure image of ab141245, Levofloxacin, Fluoroquinolone antibiotic

Key facts

CAS number

100986-85-4

Purity

>98%

Form

Solid

form

Molecular weight

361.4 Da

Molecular formula

C<sub>1</sub><sub>8</sub>H<sub>2</sub><sub>0</sub>FN<sub>3</sub>O<sub>4</sub>

PubChem

149096

Nature

Synthetic

Solubility

Soluble in DMSO to 100 mM

Soluble in ethanol to 10 mM

Soluble in water to 25 mM

Biochemical name

Levofloxacin

Biological description

Fluoroquinolone antibiotic. Effective against Gram-positive and Gram-negative bacteria. Pharmacologically active following oral administration. Crosses the blood-brain barrier.

Canonical smiles

CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O

Isomeric smiles

C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O

InChi

InChI=1S/C18H20FN3O4/c1-10-9-26-17-14-11(16(23)12(18(24)25)8-22(10)14)7-13(19)15(17)21-5-3-20(2)4-6-21/h7-8,10H,3-6,9H2,1-2H3,(H,24,25)/t10-/m0/s1

InChiKey

GSDSWSVVBLHKDQ-JTQLQIEISA-N

IUPAC Name

(2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
The product can be stored for up to 12 months

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

TDP1 is also known as tyrosyl-DNA phosphodiesterase 1. This enzyme plays an important role in repairing DNA by resolving topoisomerase I-DNA covalent complexes. TDP1 has a molecular mass of approximately 68 kDa. It is expressed in various tissues with notable levels in human brain heart and testis. RCE1 which stands for Ras converting enzyme 1 is involved in the processing of CAAX proteins by cleaving the C-terminal peptide. RCE1 has a molecular mass of 35 kDa and is mainly found in cellular membranes. MATE-1 or multidrug and toxin extrusion protein 1 functions as an efflux transporter and is located in various tissues including liver and kidney.
Biological function summary

TDP1 supports genomic stability by hydrolyzing the phosphodiester bond between the tyrosine of topoisomerase I and DNA. This process is critical for the accuracy of replication machinery. RCE1 processes important signaling proteins such as Ras which affects cellular growth and differentiation. MATE-1 on the other hand exports organic cations and metabolites out of cells including antibiotic fluoroquinolone belonging to the fluoroquinolone structure group. None of these proteins are typically part of a complex but act individually to fulfill their roles.

Pathways

TDP1 interacts within the DNA repair pathway particularly homologous recombination and non-homologous end joining. It works closely with proteins like topoisomerase I and PARP1. RCE1 participates in post-translational modification pathways altering proteins like Ras and Rho which are important in signal transduction pathways. MATE-1 integrates within excretion and detoxification pathways acting alongside transporters such as the organic cation transporter family.

TDP1 mutations have been linked to neurodegenerative conditions including spinocerebellar ataxia with axonal neuropathy (SCAN1). The protein's role in DNA repair connects it to other DNA damage response proteins like ATM. Deficiencies in RCE1 function can impact Ras-mediated signaling contributing to oncogenesis and cancer progression. MATE-1 variations influence drug pharmacokinetics and have implications for treatments involving antibiotic fluoroquinolone and other drugs connecting it to transporter proteins like OCT1.

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com